S7A: Safety Pharmacology Studies for Human Pharmaceuticals

Regulatory Resource: S7A: Safety Pharmacology Studies for Human Pharmaceuticals

Description:

The ICH guideline reached Step 4 of the ICH process in November 2000. This document addresses the definition, objectives and scope of safety pharmacology studies. It also addresses which studies are needed before initiation of Phase 1 clinical studies as well as information needed for marketing.

Download Document: S7A: Safety Pharmacology Studies for Human Pharmaceuticals

0.17 Megabytes